99 related articles for article (PubMed ID: 26555753)
1. Sodium butyrate down-regulates tristetraprolin-mediated cyclin B1 expression independent of the formation of processing bodies.
Zheng XT; Xiao XQ; Dai JJ
Int J Biochem Cell Biol; 2015 Dec; 69():241-8. PubMed ID: 26555753
[TBL] [Abstract][Full Text] [Related]
2. Tristetraprolin down-regulates IL-17 through mRNA destabilization.
Lee HH; Yoon NA; Vo MT; Kim CW; Woo JM; Cha HJ; Cho YW; Lee BJ; Cho WJ; Park JW
FEBS Lett; 2012 Jan; 586(1):41-6. PubMed ID: 22138182
[TBL] [Abstract][Full Text] [Related]
3. Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling.
Marderosian M; Sharma A; Funk AP; Vartanian R; Masri J; Jo OD; Gera JF
Oncogene; 2006 Oct; 25(47):6277-90. PubMed ID: 16702957
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-466l upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolin-mediated IL-10 mRNA degradation.
Ma F; Liu X; Li D; Wang P; Li N; Lu L; Cao X
J Immunol; 2010 Jun; 184(11):6053-9. PubMed ID: 20410487
[TBL] [Abstract][Full Text] [Related]
5. Tristetraprolin suppresses AHRR expression through mRNA destabilization.
Lee HH; Kim WT; Kim DH; Park JW; Kang TH; Chung JW; Leem SH
FEBS Lett; 2013 May; 587(10):1518-23. PubMed ID: 23583445
[TBL] [Abstract][Full Text] [Related]
6. Post-transcriptional regulation of CLMP mRNA is controlled by tristetraprolin in response to TNFalpha via c-Jun N-terminal kinase signalling.
Sze KL; Lui WY; Lee WM
Biochem J; 2008 Mar; 410(3):575-83. PubMed ID: 18047469
[TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.
Hitti E; Iakovleva T; Brook M; Deppenmeier S; Gruber AD; Radzioch D; Clark AR; Blackshear PJ; Kotlyarov A; Gaestel M
Mol Cell Biol; 2006 Mar; 26(6):2399-407. PubMed ID: 16508014
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the function, expression, and subcellular distribution of human tristetraprolin.
Brooks SA; Connolly JE; Diegel RJ; Fava RA; Rigby WF
Arthritis Rheum; 2002 May; 46(5):1362-70. PubMed ID: 12115244
[TBL] [Abstract][Full Text] [Related]
9. Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.
Kim EH; Kim HS; Kim SU; Noh EJ; Lee JS; Choi KS
Oncogene; 2005 Oct; 24(46):6877-89. PubMed ID: 16007142
[TBL] [Abstract][Full Text] [Related]
10. Tristetraprolin down-regulates IL-23 expression in colon cancer cells.
Lee HH; Yang SS; Vo MT; Cho WJ; Lee BJ; Leem SH; Lee SH; Cha HJ; Park JW
Mol Cells; 2013 Dec; 36(6):571-6. PubMed ID: 24292977
[TBL] [Abstract][Full Text] [Related]
11. Histone Deacetylase Inhibitors Activate Tristetraprolin Expression through Induction of Early Growth Response Protein 1 (EGR1) in Colorectal Cancer Cells.
Sobolewski C; Sanduja S; Blanco FF; Hu L; Dixon DA
Biomolecules; 2015 Aug; 5(3):2035-55. PubMed ID: 26343742
[TBL] [Abstract][Full Text] [Related]
12. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA.
Dai XY; Cai Y; Sun W; Ding Y; Wang W; Kong W; Tang C; Zhu Y; Xu MJ; Wang X
Cardiovasc Res; 2014 Feb; 101(2):297-305. PubMed ID: 24253523
[TBL] [Abstract][Full Text] [Related]
13. Butyrate suppresses tumor necrosis factor alpha production by regulating specific messenger RNA degradation mediated through a cis-acting AU-rich element.
Fukae J; Amasaki Y; Yamashita Y; Bohgaki T; Yasuda S; Jodo S; Atsumi T; Koike T
Arthritis Rheum; 2005 Sep; 52(9):2697-707. PubMed ID: 16142751
[TBL] [Abstract][Full Text] [Related]
14. Post-Transcriptional Regulation of Immune Responses and Inflammatory Diseases by RNA-Binding ZFP36 Family Proteins.
Makita S; Takatori H; Nakajima H
Front Immunol; 2021; 12():711633. PubMed ID: 34276705
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization and polyadenylation-regulated expression of cyclin B1 and Cdc2 in porcine oocytes and early parthenotes.
Zhang DX; Cui XS; Kim NH
Mol Reprod Dev; 2010 Jan; 77(1):38-50. PubMed ID: 19705412
[TBL] [Abstract][Full Text] [Related]
16. Repression of cyclin B1 expression after treatment with adriamycin, but not cisplatin in human lung cancer A549 cells.
Dan S; Yamori T
Biochem Biophys Res Commun; 2001 Jan; 280(3):861-7. PubMed ID: 11162602
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor β regulates P-body formation through induction of the mRNA decay factor tristetraprolin.
Blanco FF; Sanduja S; Deane NG; Blackshear PJ; Dixon DA
Mol Cell Biol; 2014 Jan; 34(2):180-95. PubMed ID: 24190969
[TBL] [Abstract][Full Text] [Related]
18. IL-17 regulates CXCL1 mRNA stability via an AUUUA/tristetraprolin-independent sequence.
Datta S; Novotny M; Pavicic PG; Zhao C; Herjan T; Hartupee J; Hamilton T
J Immunol; 2010 Feb; 184(3):1484-91. PubMed ID: 20042592
[TBL] [Abstract][Full Text] [Related]
19. Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b.
Ciais D; Cherradi N; Bailly S; Grenier E; Berra E; Pouyssegur J; Lamarre J; Feige JJ
Oncogene; 2004 Nov; 23(53):8673-80. PubMed ID: 15467755
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin inhibits PD-L1 expression by enhancing TTP-mediated decay of PD-L1 mRNA in cancer cells.
Kim DJ; Jang JH; Ham SY; Choi SH; Park SS; Jeong SY; Kim BC; Jeon DY; Lee BJ; Ko BK; Park JW; Cho WJ
Biochem Biophys Res Commun; 2020 Feb; 522(2):402-407. PubMed ID: 31767150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
